Catalyst

Slingshot members are tracking this event:

Allergan (AGN) Strengthens Liver Disease Portfolio in Agreement to Acquire Tobira Therapeutics (TBRA) for ~$1.695 Billion

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AGN

100%
TBRA

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 20, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Acquisition, Multi-factoral Elements Of Nash, Cenicriviroc, Evogliptin, Nash